Retroviral vectors

Advances in Virus Research

Volumn 55, Issue , 2000, Pages 545-563

  Kim, Seon Hee ^a,b   Kim, Sunyoung ^a,b   Robbins, Paul D ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CELL LINE; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; METHODOLOGY; PHYSIOLOGY; RETROVIRUS; REVIEW;

ANIMALS; CELL LINE; GENE THERAPY; GENETIC VECTORS; HUMANS; RETROVIRIDAE;

EID: 0034575896     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/s0065-3527(00)55017-9     Document Type: Review

References (42)

1. R Dornberg Reticuloendotheliosis viruses and derived vectors Gene Ther 2 1995 301 310
2. E Gilboa M.A Eglitis P.W Kantoff W.F Anderson Transfer and expression of cloned genes using retroviral vectors Biotechiques 4 1986 504 512
3. B.C Guild M.H Finer D.E Houseman R.C Mulligan Development of retrovirus vectors usefull for expressing genes in cultured murine embryonal cells and hematopoietic cells in vivo J. Virol. 62 1988 3795 3801
4. A.D Miller D.G Miller J.V Garcia C.M Lynch Use of retroviral vectors for gene transfer and expression Methods Enzymol. 217 1993 581 599
5. R.C Mulligan The basic science of gene therapy Science 260 1993 926 932
6. P.D Robbins H Tahara G.M Mueller G Hung A Bahnson L Zitvogel J Galea-Lauri T Ohashi K Patrene S.S Boggs C.H Evans J.A Barranger M.T Lotze Retroviral vectors for use in human gene therapy for cancer, Gaucher disease, and arthritis, in Gene Therapy for Neoplastic Diseases Ann. N. Y Acad. Sci. 716 1993 72 89
7. S.H Kim S.S Yu J.S Park P.D Robbins C.S An S Kim Construction of retroviral vectors with improved safety, gene expression, and versatility J Virol. 72 1998 994 1004
8. A.D Miller G.J Roseman Improved retroviral vectors for gene transfer and expression Biotechniques 7 1989 980 990
9. C.F Boerkoel M.J Federspiel D.W Salter W Payne L.B Crittenden H.J Kung S.H Hughes A new defective retroviral vector system based on the Bryan strain of Rous sarcoma virus Virology 195 1993 669 679
10. H Wang M.P Kavanough R.A North D Kabat Cell surface receptor for ecotropic murine retroviruses is a basic amino acid transporter Nature 352 1991 729 731
11. D.G Miller A.D Miller A family of retroviruses that utilize related phosphate transporters for cell entry J. Virol. 68 1994 8270 8276
12. P.F Lewis M Emerman Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency J. Virol. 68 1994 510 516
13. P Galley S Swingler C Aiken D Trono HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator Cell 80 1995 379 388
14. M.I Bukrinsky S Haggerty M.P Dempsey N Sharova A Adzhubel L Spitz P Lewis D Goldfarb M Emerman M Stevenson A nuclear localization signal within HIV-1 matrix protein that governs infections of non-dividing cells Nature 365 1993 666 669
15. I Reviere K Brose R.C Mulligan Effects of retroviral design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells 2nd ed. Proc. Natl. Acad. Sci. U.S.A. 92 1995 6733 6737
16. L.A Couture C.A Mullen R.A Morgan Retroviral vectors containing promoter/enhancer elements exhibit cell-type-specific gene expression Hum. Gene Ther. 5 1994 667 677
17. R.A Morgan L Couture O Elroy-Stein J Ragheb B Moss W.F Anderson Retroviral vectors containing putative internal ribosome entry sites: Development of a polycistronic gene transfer system and applications to human gene therapy Nucleic Acids Res. 20 1992 1293 1299
18. L Zitvogel H Tahara G Mueller S.F Wolf U Gubler M Gately P.D Robbins M.T Lotze Construction and characterization of retroviral vectors expressing biologically active human interleukin 12 Hum. Gene Ther. 5 1994 1493 1506
19. I.R Ghattas J.R Sanes J.E Majors The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos Mol. Cell. Biol. 11 1991 5848 5859
20. G Drano E Jaffee A Lazenby P Golumbek H Levitsky K Brose V Jackson H Hamada D Pardoll R.C Mulligan Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity 2nd ed. Proc. Natl. Acad. Sci. U.S.A. 90 1993 3539 3543
21. M Sadelain C.H Wang M Antoniou F Grosveld R.C Mulligan Generation of a high titer retroviral vector capable of expressing high levels of the human beta-globin gene 2nd ed. Proc. Natl. Acad. Sci. U.S.A. 92 1995 6728 6732
22. E.A Dzierzak T Papayannopoulou R.C Mulligan Lineage-specific expression of a human beta-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells Nature 331 1988 35 41
23. M.A Adam A.D Miller Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions J. Wirol. 62 1988 3802 3806
24. M.A Bender T.D Palmer R.E Gelinas A.D Miller Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region J Virol. 61 1987 1639 1646
25. J Byun S.H Kim J.M Kim S.S Yu P.D Robbins J Yim S Kim Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy Gene Ther. 3 1996 780 788
26. W.J Kral D.C Skelton X.J Yu I Reviere P Lehn R.C Mulligan D.B Kohn Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells Gene Ther. 3 1995 37 48
27. R Mann R.C Mulligan D Baltimore Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus Cell. 33 1983 153 159
28. R.D Cone R.C Mulligan High efficiency gene transfer into mammalian cells: Generation of helper free recombinant retrovirus with broad mammalian host range 2nd ed. Proc. Natl. Acad. Sci. U.S.A. 81 1984 6349 6353
29. A.D Miller C Buttimore Redesign of retrovirus packaging lines to avoid recombination leading to helper virus production Mol. Cell. Biol. 6 1986 2895 2902
30. O Danos R.C Mulligan Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges 2nd ed. Proc. Natl. Acad. Sci. U.S.A. 85 1988 6460 6464
31. D.G Markowitz S.P Goff A Bank Safe and efficient ecotropic and amphotropic packaging lines for use in gene transfer experiments Trans. Assoc. Am. Physicians 101 1988 212 218
32. F.L Cosset Y Takeuchi J.L Battini R.A Weiss M.K Collins High-titer packaging cells producing recombinant retroviruses resistant to human serum J. Virol. 69 1995 7430 7436
33. T.M Kinsella G.P Nolan Episomal vectors rapidly and stably produce high-titer recombinant retrovirus Hum. Gene Ther 7 1996 1405
34. W.S Pear G.P Nolan M.L Scott D Baltimore Production of hightiter helper free retroviruses by transient transfection 2nd ed. Proc. Natl. Acad. Sci. U.S.A. 90 1993 8392 8396
35. A.D Miller J.V Garcia N von Suhr C.M Lynch M.V Eiden Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus J. Viol. 65 1991 2220 2224
36. T Fridmann J.K Yee Pseudotyped retroviral vectors for studies of human gene therapy Nat. Med. 1 1995 275 277
37. W.H Gunzberg A Feuchaus R Saller B Salmons Retroviral vector targeting for gene therapy Cyokines Mot. Ther. 2 1996 177 184
38. K.W Peng S.J Russell Viral vector targeting Curr Opin. Biotechnol. 10 1999 454 457
39. A Jiang T.H Chu F Nocken K Cichuteck Dornburg Cell-typespecific gene transfer into human cells with retroviral vectors that display singlechain antibodies J. Virol. 72 1998 10148 10156
40. N.V Somia M Zoppe I.M Verma Generation of targeted retroviral vectors by using single-chain variable fragment: An approach to in vivo gene delivery 2nd ed. Proc. Natl. Acad. Sci U.S.A. 92 1995 7570 7574
41. N Kasahara A.M Dozy Y.W Kan Tissue-specific targeting of retroviral vectors throught ligan-receptor interactions Science 266 1994 1373 1376
42. X Han N Kasahara Y.W Kan Ligand-directed retroviral targeting of human breast cancer cells 2nd ed. Proc. Natl. Acad. Sci. U.S.A. 92 1995 9747 9751